ABBN.SW: $86.66 ▲ 0.56 (0.65%)ASML.AS: $1,577.00 ▲ 16.20 (1.04%)ENR.DE: $159.42 ▼ -3.08 (-1.90%)GLEN.L: $523.50 ▼ -11.80 (-2.20%)IFX.DE: $81.06 ▲ 0.50 (0.62%)NOKIA.HE: $12.37 ▲ 0.37 (3.04%)RIO.L: $7,205.00 ▼ -59.00 (-0.81%)AMD: $519.85 ▼ -31.78 (-5.76%)INTC: $132.28 ▼ -8.66 (-6.14%)MU: $1,051.77 ▼ -159.61 (-13.18%)WDC: $670.75 ▼ -61.87 (-8.45%)AAPL: $294.30 ▼ -2.71 (-0.91%)AMZN: $234.11 ▲ 1.32 (0.57%)NVDA: $200.04 ▼ -8.61 (-4.13%)AMAT: $585.88 ▼ -54.30 (-8.48%)CIEN: $459.85 ▼ -0.48 (-0.10%)STX: $1,038.59 ▼ -55.45 (-5.07%)

Company Details

VanEck Biotech ETF

BBH - NASDAQ

Identifiants & Marche

Ticker BBH
ISIN US92189F7261
CIK 0001137360
Bourse NASDAQ
Devise USD

Classification

Industrie Asset Management

Entreprise

Pays US
Siege N/A
Fondee N/A
Site Web N/A

Description

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.